Article Versions Notes

Sanabria J, Garzón V, Pacheco T, Avila M-P, Garcia J-C, Jaimes D, Torres A, Bustos R-H, Escobar-Perez J, Abril D. Estimation of the Difference in Colistin Plasma Levels in Critically Ill Patients with Favorable or Unfavorable Clinical Outcomes. Pharmaceutics. 2021; 13(10):1630. https://doi.org/10.3390/pharmaceutics13101630

Sanabria, Jose, Vivian Garzón, Tatiana Pacheco, Maria-Paula Avila, Julio-Cesar Garcia, Diego Jaimes, Angela Torres, Rosa-Helena Bustos, Javier Escobar-Perez, and Deisy Abril. 2021. "Estimation of the Difference in Colistin Plasma Levels in Critically Ill Patients with Favorable or Unfavorable Clinical Outcomes" Pharmaceutics 13, no. 10: 1630. https://doi.org/10.3390/pharmaceutics13101630

Sanabria, J., Garzón, V., Pacheco, T., Avila, M.-P., Garcia, J.-C., Jaimes, D., Torres, A., Bustos, R.-H., Escobar-Perez, J., & Abril, D. (2021). Estimation of the Difference in Colistin Plasma Levels in Critically Ill Patients with Favorable or Unfavorable Clinical Outcomes. Pharmaceutics, 13(10), 1630. https://doi.org/10.3390/pharmaceutics13101630